Search

You searched for "PSA"

236 results found

What did the Romans ever do for us?

1 May 2016 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). Previously in this column, I told you about the Saxons and how they...

Impact of case volume on outcomes of ureteroscopy for ureteral stones

1 May 2015 | | URO - Endourology & Stones
With the ever-increasing focus on patient safety, centralisation of services for major procedures is becoming more common. Using data from the Clinical Research Office of the Endourological Society (CROES) Ureteroscopy Global Study database, a prospective observational multicentre study created to...

LUTS update

8 January 2024 | | URO - Functional / Reconstructive Urology
Case study A 70-year-old, generally fit and well male attends your outpatient clinic. He has experienced a gradual deterioration in his voiding over the last few months. Specifically, he reports hesitancy, poor flow and nocturia. He denies visible haematuria. His...

So you want to be a urologist?

1 March 2017 | | URO - Core Urology
Urology is a varied, innovative and friendly speciality and it is easy to see why so many people are attracted to it. The article below is designed to help all doctors wishing to apply for an ST3 post get the...

COVID-19: the impact on a junior registrar

26 May 2020 | | URO - Covid-19
Prior to the coronavirus pandemic I was a trust grade junior registrar, using this year at a district general hospital to gain experience, skills and portfolio points for round two of National Selection. My urology registrar on-call duties would consist...

Black men are more at risk from prostate cancer, but we won’t let it stay that way – an update from Prostate Cancer Research

4 May 2023 | | URO - Urologic Oncology
- CHARITY FOCUS - Focusing on all of disease characteristics, societal factors, and better communication gives us real potential to fix a disparity that has persisted for too long. When it comes to health inequity, the numbers are stark. Black...

BAUS Annual Scientific Meeting 2024

9 July 2024 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatric Urology, URO - Core Urology, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Day 1 Toni Huw Mihailidis and Mriganka Mani Sinha Another year and another brilliant meeting in which urologists from the UK and around the globe assembled for a highly entertaining event. Day one kicked off with a topical and ever-pervasive...

Neuroendocrine bladder tumour

5 February 2025 | | URO - Urologic Oncology
A 75-year-old male with a history of prostate adenocarcinoma (T3b/T4 N1 M1b, Gleason 4+3) on Zoladex® and enzalutamide, presented with visible haematuria. His prostate specific antigen (PSA) had decreased from 43.6ug/L in December 2022 to 0.02ug/L. He also had a...

Can dogs smell prostate cancer?

4 March 2025 | | URO - Urologic Oncology
For centuries we have known that man’s best friend has an exceptional sense of smell. ‘Sniffer’ dogs are found in a wide range of roles, including drug and explosive detection as part of airport security, helping emergency services locate survivors...

BUI (Bristol Urological Institute) 30th Annual Scientific Meeting : Andrology Theme

5 December 2024 -6 December 2024
Invited Professors: Professor Arthur Burnett, Johns Hopkins Hospital, Baltimore, USA. Professor David Ralph, UCLH London Professor Ian Pearce, Manchester

Nurse practitioner TRUS biopsy: training and preparation

1 May 2014 | | URO - Urologic Oncology
As prostate cancer rates increase, many urology departments rely on multi-professional teams to diagnose and manage patients with prostate cancer. The aim of this article is to highlight the skills, training and preparation required for nurse practitioners to undertake trans-rectal...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...